Literature DB >> 17504805

Inadequate antimicrobial prophylaxis during surgery: a study of beta-lactam levels during burn debridement.

Andrew J Dalley1, Jeffrey Lipman, Bala Venkatesh, Michael Rudd, Michael S Roberts, Sheree E Cross.   

Abstract

OBJECTIVES: To determine how long single-dose prophylactic antibiotic regimens for burns surgery maintained plasma concentrations above the MICs for target organisms during surgery. PATIENTS AND METHODS: We monitored antibiotic plasma concentrations in 12 patients (mean +/- SD 43 +/- 12% total burn surface area) throughout debridement surgery after administration of the standard prophylactic antibiotic dosing regimens of either 1 g of intravenous cefalotin or 4.5 g of intravenous piperacillin/tazobactam.
RESULTS: The eschar debridement and grafting procedures ranged in duration from 2.25 to over 8.5 h. The duration of total plasma cefalotin concentration above an MIC of 0.2 mg/L for Staphylococcus aureus was 6.49 +/- 2.85 h, whereas the mean duration of total plasma piperacillin concentration above an MIC of 64 mg/L for Pseudomonas aeruginosa was only 1.15 +/- 0.59 h. None of the patients dosed with piperacillin/tazobactam was adequately protected for the duration of their surgery and adequate prophylaxis was only evident in four of the nine patients administered cefalotin.
CONCLUSIONS: These results suggest a need to review antibiotic prophylaxis dosage regimens for burns surgery and the adoption of regimens that will minimize the risk of infection in this high-risk patient group. It is suggested that the antibiotic prophylaxis guideline for burn debridement surgery be modified to include re-dosing or a continuous infusion of beta-lactam antibiotics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17504805     DOI: 10.1093/jac/dkm128

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases.

Authors:  K de With; F Allerberger; S Amann; P Apfalter; H-R Brodt; T Eckmanns; M Fellhauer; H K Geiss; O Janata; R Krause; S Lemmen; E Meyer; H Mittermayer; U Porsche; E Presterl; S Reuter; B Sinha; R Strauß; A Wechsler-Fördös; C Wenisch; W V Kern
Journal:  Infection       Date:  2016-06       Impact factor: 3.553

2.  Tissue accumulation of cephalothin in burns: a comparative study by microdialysis of subcutaneous interstitial fluid cephalothin concentrations in burn patients and healthy volunteers.

Authors:  Andrew J Dalley; Jeffrey Lipman; Renae Deans; Bala Venkatesh; Michael Rudd; Michael S Roberts; Sheree E Cross
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

3.  A retrospective surveillance of the prophylactic antibiotics for debridement surgery in burn patients.

Authors:  Oki Nugraha Putra; Iswinarno Doso Saputro; Affan Yuniar Nur Hidayatullah
Journal:  Int J Burns Trauma       Date:  2021-04-15

4.  Fms-like tyrosine kinase-3 ligand alters antigen-specific responses to infections after severe burn injury.

Authors:  Julia Bohannon; Geping Fang; Weihua Cui; Edward Sherwood; Tracy Toliver-Kinsky
Journal:  Shock       Date:  2009-10       Impact factor: 3.454

5.  Unbound cephalothin pharmacokinetics in adult burn patients are related to the elapsed time after injury.

Authors:  Andrew J Dalley; Renae Deans; Jeffrey Lipman; Bala Venkatesh; Michael Rudd; Michael S Roberts; Sheree E Cross
Journal:  Antimicrob Agents Chemother       Date:  2009-09-14       Impact factor: 5.191

6.  The pharmacokinetics of cefazolin in patients undergoing elective & semi-elective abdominal aortic aneurysm open repair surgery.

Authors:  Alexandra Douglas; Mahdi Altukroni; Andrew A Udy; Michael S Roberts; Kersi Taraporewalla; Jason Jenkins; Jeffrey Lipman; Jason A Roberts
Journal:  BMC Anesthesiol       Date:  2011-02-22       Impact factor: 2.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.